Press release · May 6, 2025 · Princeton, NJ

We are attending CPHI Americas 2025

Back to home

BIOVERIC Pharmaceuticals, Inc. will be attending the upcoming CPHI Americas 2025 conference, which will take place from May 20th to 22nd in Philadelphia, USA.

This event is an excellent opportunity to explore the latest advancements and innovations in the industry, connect with other professionals, and discuss potential business opportunities.

We are looking forward to connecting with you!

BIOVERIC's programs are investigational product candidates. They have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory agency, and their safety and effectiveness have not been established.

← All news